Hypertension, hyperlipidaemia and thrombophilia as the most common risk factors for retinal vein occlusion in patients under 50 years
Language English Country Czech Republic Media print-electronic
Document type Journal Article
PubMed
36036564
DOI
10.5507/bp.2022.036
Knihovny.cz E-resources
- Keywords
- arterial hypertension, congenital thrombophilic disorder, hyperlipidaemia, retinal vein occlusion, risk factors, systemic comorbidities, younger patients,
- MeSH
- Glaucoma * MeSH
- Hyperlipidemias * complications epidemiology MeSH
- Hypertension * complications epidemiology MeSH
- Cardiovascular Diseases * MeSH
- Humans MeSH
- Sleep Apnea, Obstructive * MeSH
- Retinal Vein Occlusion * epidemiology etiology MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Thrombophilia * complications MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND AND AIMS: Cardiovascular (CV) diseases are the most common risk factors (RFs) for retinal vein occlusion (RVO) development in general. The aim of this study was to identify the most frequent causes of RVO in patients under 50. METHODS: We retrospectively evaluated a group of patients with RVO under 50 years. The parameters of interest included age and sex, RVO type, presence of arterial hypertension (HT), hyperlipidaemia (HLD), diabetes mellitus (DM), congenital thrombophilic disorder (TD), obstructive sleep apnoea syndrome (OSAS), thyroid eye disease (TED), use of hormone contraception (HC) or hormone replacement therapy (HRT), glaucoma and other potential RFs. Patients with central RVO (CRVO), hemi-central RVO (HRVO), branch RVO (BRVO), impending CRVO and combined arterial-venous (AV) occlusion were included. RESULTS: The group consisted of 110 eyes of 103 patients. CV disease was the most common systemic abnormality. 55.3% patients had HT, 17.5% had HLD. TD was the third most frequent RF (12.6%). The cohort also included patients with DM (6.8%), glaucoma (6.8%) and women using HC/HRT (26.2% of female patients). There were isolated cases of RVO due to retinal vasculitis, intense exercise, antiphospholipid syndrome and COVID-19 pneumonia. None of the patients had OSAS, TED or a haemato-oncological disease. The etiology remained unexplained in 20.4% patients. No difference was observed in RF occurrence between patients with CRVO and HRVO and those with BRVO. CONCLUSION: The most common systemic abnormality in our cohort was CV disease, especially HT and HLD. The risk factors for central, hemi-central and branch RVOs were similar.
See more in PubMed
Rehak J, Rehak M, Fric E, Jurecka T, Kolar P, Krcova V, Mach R, Nemec P, Sin M, Spackova K. Retinal Vein Occlusions [Venózní okluze sítnice]. 1st ed. Praha: Grada publishing, 2011, p.144. (In Czech)
Sivaprasad S, Amoaku W, Williamson T, Dodson P, Talks J, Talks K, Bhan K, Hykin P. Retinal Vein Occlusion (RVO) Guidelines [Internet]. London: The Royal College of Ophthalmologists; 2015 Jul [cited 2021 Nov 18]. Available from: https://www.rcophth.ac.uk/wp-content/uploads/2015/07/Retinal-Vein-Occlusion-RVO-Guidelines-July-2015.pdf
Salmon JF. Kanski's Clinical Ophthalmology. 9th ed. Oxford: Elsevier Books, 2020, p.956.
Klein R, Moss SE, Meuer SM, Klein BEK. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008;126(4):513-18. DOI
Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-43.
Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010;8(9):1886-94. DOI
Hayreh SS, Hayreh MS. Hemi-central retinal vein occlusion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol 1980;98(9):1600-9. DOI
Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117(4):429-41. DOI
Yau JW, Lee P, Wong TY, Best J, Jenkins A. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 2008;38(12):904-10. DOI
Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005;24(4):493-519. DOI
Sinová I, Rehak J, Nekolova J, Jiraskova N, Haluzova P, Rehakova T, Babkova B, Hejsek L, Sin M. Correlation Between Ischemic Index of Retinal Vein Occlusion and Oxygen Saturation in Retinal Vessels. Am J Ophthalmol 2018;188:74-80. DOI
Hübnerova P, Mlcak P, Sinova I, Karhanova M, Sin M. Current use of the automatic retinal oximetry. Review. Cesk Slov Oftalmol 2020;76(1):3-11. DOI
Osaka R, Nakano Y, Takasago Y, Fujita T, Yamashita A, Shiragami C, Muraoka Y, Tsujikawa A. Retinal oximetry in branch retinal vein occlusion. Acta Ophthalmol 2019;97(6):e896-e901. doi: 10.1111/aos.14070 PubMed DOI
Jeppesen SK, Bek T. Retinal Oxygen Saturation Correlates With Visual Acuity but Does Not Predict Outcome After Anti-VEGF Treatment in Central Retinal Vein Occlusion. Invest Ophthalmol Vis Sci 2017;58(5):2498-502. DOI
Hardarson SH, Stefánsson E. Oxygen saturation in central retinal vein occlusion. Am J Ophthalmol 2010;150(6):871-5. DOI
Cheung N, Klein R, Wang JJ, Cotch MF, Islam AFM, Klein BEK, Cushman M, Wong TY. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci 2008;49(10):4297-302. DOI
Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131(1):61-77. DOI
Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY, International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117(2):313-9. DOI
O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126(5):692-9. DOI
Chen TY, Uppuluri A, Zarbin MA, Bhagat N. Risk factors for central retinal vein occlusion in young adults. Eur J Ophthalmol 2021;31(5):2546-555. doi: 10.1177/1120672120960333 PubMed DOI
Chen J, Mueller B, Hadayer A, Schaal S. Retinal Vein Occlusion in Young Patients: Risk Factors and Management. Invest. Ophthalmol Vis Sci 2019;60(9):4081.
Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J. The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 2010;45(2):171-5. DOI
Janssen MC, Den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJH. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005;93(6):1021-6. DOI
Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol 2014;2014:724780. doi: 10.1155/2014/724780 PubMed DOI
Rehak M, Rehak J, Müller M, Faude S, Siegemund A, Krcova V, Slavik L, Hasenclever D, Scholz M, Wiedemann P. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis. Thromb Haemost 2008;99(5):925-9. DOI
Rehak M, Müller M, Scholz M, Wiercinska J, Niederwieser D, Wiedemann P. Antiphospholipidsyndrom und retinale venöse Verschlüsse. Metaanalyse publizierter Studien [Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of Published Studies]. Ophthalmologe 2009;106(5):427-34. (In German) DOI
Li D, Zhou M, Peng X, Sun H. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis. BMC Ophthalmol 2014;14:147. DOI
Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Current eye research 2008;33(2):111-31. DOI
Ahluwalia J, Rao S, Varma S, Gupta A, Bose S, Masih J, Das R, Kumar N, Naseem S, Sharma P, Sachdeva MUS, Varma N. Thrombophilic risk factors are uncommon in young patients with retinal vein occlusion. Retina 2015;35(4):715-9. DOI
Figueiredo L, Rothwell R, Brandão A, Fonseca S. Central retinal vein occlusion in a patient with retinal vasculitis and Crohn's disease. Case Rep Ophthalmol Med 2014;2014:967878. doi: 10.1155/2014/967878 PubMed DOI
Thapa R, Paudyal G. Central retinal vein occlusion in young women: rare cases with oral contraceptive pills as a risk factor. Nepal Med Coll J 2009;11(3):209-11. DOI
Yin X, Li J, Zhang B, Lu P. Association of glaucoma with risk of retinal vein occlusion: A meta-analysis. Acta Ophthalmol 2019;97(7):652-59. DOI
Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol 2009;16(4):202-18.
Williamson TH. A ´throttle´mechanism in the central retinal vein in the region of the lamina cribrosa. Br J Ophthalmol 2007;91:1190-193. DOI
Borgman CJ. Concomitant multiple myeloma spectrum diagnosis in a central retinal vein occlusion: a case report and review. Clin Exp Optom 2016;99(4):309-12. DOI
Roelofs KA, Eliott D, Freitag SK. Central Retinal Vein Occlusion with Chorioretinal Folds Secondary to Active Thyroid Eye Disease. Ophthalmology 2018;125(10):1645. doi: 10.1016/j.ophtha.2018.07.001 PubMed DOI
Moisseiev E, Sagiv O, Lazar M. Intense exercise causing central retinal vein occlusion in a young patient: case report and review of the literature. Case Rep Ophthalmol 2014;5(1):116-20. DOI
Francis PJ, Stanford MR, Graham EM. Dehydration is a risk factor for central retinal vein occlusion in young patients. Acta Ophthalmol Scand 2003;81(4):415-6. DOI
Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol 2021;69(3):488-509. DOI
Duff SM, Wilde M, Khurshid G. Branch Retinal Vein Occlusion in a COVID-19 Positive Patient. Cureus 2021;13(2):e13586. doi: 10.7759/cureus.13586 PubMed DOI
Nourinia R, Ghassempour M, Ahmadieh H, Abtahi SH. Branch retinal vein occlusion after COVID-19. J Fr Ophtalmol 2021;44(8):e441-e443. doi: 10.1016/j.jfo.2021.06.003 PubMed DOI
Agard E, El Chehab H, Vie AL, Voirin N, Coste O, Dot C. Retinal vein occlusion and obstructive sleep apnea: a series of 114 patients. Acta Ophthalmol 2018;96(8):e919-e925. doi: 10.1111/aos.13798 PubMed DOI
Glacet-Bernard A, Leroux les Jardins G, Lasry S, Coscas G, Soubrane G, Souied E, Housset B. Obstructive sleep apnea among patients with retinal vein occlusion. Arch Ophthalmol 2010;128(12):1533-8. DOI
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230-5. DOI
Eah KS, Kim YN, Park YJ, Lee JY, Kim JG, Yoon YH, Kim YJ. Central Retinal Vein Occlusion in Young Patients: Clinical Characteristics and Prognostic Factors. Retina 2021;41(3):630-37. DOI